Peterlin B, Canki N, Morela V, Stirn B, Cerar V. Prevalence of Retinitis pigmentosa in Slovenia. Clin Genet 1992;42:122-3

Ravnik-Glavač M, Gasparini P, Peterlin B, Štrukelj M, Glavač D, Canki Klain N, Pignatti PF, Komel R. Cystic fibrosis gene mutations and linked RFLPs in the Slovenia population. Ann Genet 1992;35:85-8

Peterlin B, Smahi A, Holvoet-Vermaut L, Heitz D, dahl N, Hors Cayala MC. An irradiation reduced hybrid (IRH) panel for fine structure maping in the Xq28 region. Cytogenet Cell Genet 1993;62:58-9

Smahi A, Hyden G, Peterlin B, Vabres P, Heuertz S, Fluchignoni-Lataud MC, Dahl N, Labrune P, Marec B, Piussan C, Taieb A, von Koskull H, Hors Cayla MC. The gene for the familial form of incontinenca pigmenti (IP2) maps to the distal part of Xq28. Hum Mol Genet 1994;2:273-8

Smahi A, Peterlin B, Onodera O, Tsuji S, Fluchignoni-Lataud MC. Use of radiation-reduced hybrid panel for the localisation of seven markers in the Xq28 region of the human genome. Ann Genet 1994;37:11-3

Petrovič D, Keber I, Zorc M, Peterlin B. I/D polymorphism at the locus for ACE and apo A-I gene promoter polymorphism as risk factors for coronary artery disease in patients with familial hypercholesterolemia. Pflugers Arch Eur J Phy 1996; 431 (Suppl): R197-8.

Leonardis L, Zidar J, Trontelj J, Peterlin B. Correlations between clinical, electrophysiological and genetic findings in hereditary motor and sensory neuropathy type I (HMSN I). Pflugers Arch Eur J Phy1996; 431 (Suppl): R195-6.

Peterlin B, Logar N, Zidar J. CTG repeat analysis in lymphocytes, muscles and fibroblasts in patients with myotonic dystrophy. Pflugers Arch Eur J Phy 1996; 431 (Suppl): R199-200.

Peterlin B. Genetic services in Slovenia. Eur J Hum Genet 1997; 5(Suppl2): 159-62.

Peterlin B, Zidar J, Meznarič-Petruša M, Zupančič J. Genetic epidemiology of Duchenne and Becker muscular dystropy in Slovenia. Clin Genet 1997; 51: 94-7.

Medica I, Marković D, Peterlin B. Genetic epidemiology of myotonic dystrophy in Istria, Croatia. Acta Neurol Scand 1997; 95(3): 164-6.

Turco AE, Bresin E, Rossetti S, Peterlin B, Morandi R, Pignatti PF. Rapid DNA-based prenatal diagnosis by genetic likage in three families with alport’s syndrome. Am J Kidney Dis 1997; 30(2): 174-9.

Devilee P, Hermans J, Eyfjord J, Borresen AL, Lidereav R, Sobol H, Borg A, Cleton-Jansen AM, Olah E, Peterlin B, Caligo M, Bignon YJ, Maugard C. Loss of heterozygosity at 7q31 in breast cancer: results from an International collaborative study group. Gene Chromosomes Cancer 1997; 18(3): 193-9.

Stirn-Kranjc B, Brezigar A, Peterlin B. Bilateral macular dysplasia in fragile X syndrome. Optom Vis Sci 1998; 75(12):856-59.

Leonardis L. Zidar J. Ekici A. Peterlin B. Rautenstrauss B. Autosomal dominant Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies: detection of the recombination "hotspot" in Slovene patients and exclusion of the potentially recessive Thr118Met PMP22 point mutation. Int J Mol Med 1998; 1 495-501.

Medica I, Logar N, Batagelj M, Peterlin B. Characteristics of moyotonic dystrophy in Istria: molecular genetics approach - mutation analysis. Coll Antropol 1998; 22(2):477-84.

Laake K, Launonen V, Niederacher D, Gudlaugsdottir S, Seitz S, Rio P, Champeme M-H, Bieche I, Sever N, Peterlin B, Olah E, Borresen-Dale AL. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Genes Chromosomes Cancer 1999; 25(3):212-21.

Launonen V, Laake K, Huusko P, Niederacher D, Beckmann MW, Barkardottir RB, Geirsdottir EK, Gudmundsson J, Velikonja N, Peterlin B, Winqvist R. European multicenter study on LOH of APOC3 at 11q 23 in 766 breast cancer patients: relation to clinical variables. Breast cancer somatic genetics consortium. Br J Cancer 1999; 80(5-6):879-82.

Rosser ZH, Zerjal T, Hurles ME, Adojaan M, Alavantic D, Amorim A, Amos W,Armenteros M, Arroyo E, Barbujani G, Beckman G, Beckman L, Bertranpetit J, Bosch E, Bradley DG, Brede G, Cooper G, Corte-Real HB, de Knijff P, Decorte R, Dubrova YE, Evgrafov O, Gilissen A, Glisic S, Golge M, Hill EW, Jeziorowska A, Kalaydjieva L, Kayser M, Kivisild T, Kravchenko SA, Krumina A, Kucinskas V, Lavinha J, Livshits LA, Malaspina P, Maria S, McElreavey K, Meitinger TA, Mikelsaar AV, Mitchell RJ, Nafa K, Nicholson J, Norby S, Pandya A, Parik J, Patsalis PC, Pereira L, Peterlin B, Pielberg G, Prata MJ, Previdere C, Roewer L, Rootsi S, Rubinsztein DC, Saillard J, Santos FR, Stefanescu G, Sykes BC, Tolun A, Villems R, Tyler-Smith C, Jobling MA Y-Chromosomal Diversity in Europe Is Clinal and Influenced Primarily by Geography, Rather than by Language. Am J Hum Genet 2000 67(6):1526-1543

Džeroski S. Hristovski D. Peterlin B. Using gata mining and OLAP to discover patterns in a database of patients with Y-chromosome deletions. J Am Med Inform Assoc 2000; (Suppl):215-9.

Petrovic D, Zorc M, Peterlin B. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease. Folia Biol (Praha) 2000;46(5):181-5

Perkovič T, Duh D, Peterlin B, Gregorič J. The Str mouse as a model for incontinentia pigmenti. Pflugers Arch 2000; 440(5 Suppl):R53-4.

Peterlin B, Petrovič D, Zorc M, Keber I. Deletion/insertion polymorphism in the angiotension-converting enzyme gene as a risk factor in the Slovenian patients with coronary heart disease. Pflugers Arch 2000; 439(3 Suppl):R40-1.

Peterlin B, Milanez T, Kobal J, Peterlin-Potisk K, Petrovič D, Grad A, Pogačnik T. DD genotype of the angiogensin-converting enzyme gene and stroke in Slovenian population. Pflugers Arch 2000; 439(3 Suppl):R38-9.

Marčun-Varda N, Peterlin B, Umek-Bradač S, Gregorič A, Milanez T. Angiotensin-converting enzyme gene polymorphism as a cardiovascular risk factor in children. Pflugers Arch 2000; 439(3 Suppl):R34-5.

Janko M, Trontelj JV, Geršak K. Fasciculations in motor neuron disease: discharge rate reflects extent and recency of collateral sprouting. J Neurol Neurosurg Psychiatry 1989; 52 1375-81.

Geršak K, Meden-Vrtovec H, Tomaževič T. Utjecaj analoga GnRH na rast folikula u bolesnica s policističnim ovarijima pri IVF-ET postupku. Gynaecol Perinatol 1992; 1(1):5-8.

Geršak K, Meden-Vrtovec H, Tomaževič T. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme. Hum Reprod 1994; 9(9):1596-9.

Geršak K, Tomaževič T. Influence of follicular phase duration on human granulosa-luteal cell subpopulations in natural and stimulated IVF-ET cycles. J Assist Reprod Genet 1995; 12(9):650-6.

Geršak K, Tomaževič T. Subpopulations of human granulosa-luteal cells in natural and stimulated in vitro fertilization-embryo transfer cycles. Fertil Steril 1996; 65(3):608-13.

Geršak K, Tomaževič T, Meden-Vrtovec H. Subpopulations of human granulosa-luteal cells obtained during early timed and during normally timed follicular aspiration in in-vitro fertilization-embryo transfer cycles. Fertil Steril 1997; 68(6):1093-6.

Geršak K, Seppaelae M, Us-Krašovec M. The same luteinized granulosa-luteal cells from normal and superovulated human chorionic gonadotropin (hCG)-stimulated cycles contain hCG and insulin-like growth factor binding protein-1. Fertil Steril 1999; 71(5):902-6.

Geršak K, Tomaževič T. Subpopulations of human granulosa-luteal cells obtained from gonadotropin - or gonadotropin-releasing hormone agoinst/gonadotropin-treated follicles in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet 1999; 16(9):488-91.

Tomaževič T, Geršak K, Meden-Vrtovec H, Drobnič S, Veble A, Valentinčič B, Kermavner-Bačer L, Virant-Klun I, Žemva Ž. Clinical parameters to predict the success of in vitro fertilization-embryo transfer in the natural cycle. Assist Reprod 1999; 9(3):149-56.

Geršak K, Lavrencak J, Us-Krasovec M. DNA ploidy of human granulosa cells from natural and stimulated in vitro fertilization cycles. Fertil Steril 2000; 74(1): 158-161.

Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, Milsom SR, Love DR, Geršak K, Aittomäki K, Winship IM. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000: 15: 2644-49.

Geršak K, Lavrencak J, Us-Krasovec M. The  consistency of ploidy analysis for granulosa cells at different stages of development.
Replay of the authors. Fertil Steril 2001; 75: 448-9.

Logar N, Zidar J, Peterlin B. Normal (CTG)n repeat expansion in a family with a clinical picture of myotonic dystrophy. Acta Cardiomiol 1996; 8: 99-101

Medica I, Logar N, Marković D, Peterlin B. Direct molecular analysis of patients with myotonic dystrophy in Istria-Croatia. Acta Cardiomiol 1996; 8: 103-6

Peterlin B, Logar N, Zidar J. CTG repeat analysis in lymphocytes, muscles and fibroblasts in patients with myotonic dystrophy. Eur J Physiol 1996; 431 (Suppl):R199-R200

Peterlin B, Medica I, Logar N, Ladovec E, Batagelj M. Piljan S. Cataract patients as potential carriers of myotonic dystrophy mutations. Eur J Hum Genet 1996; 4 (Suppl 1): 119

Medica I, Logar N, Batagelj M, Peterlin B. Characteristics of myotonic dystrophy in Istria: Molecular genetics approach-mutation analysis. Coll Antropol (1998); (22) 2: 477-484.

Medica I, Logar N, Peterlin B. Characteristics of Myotonic Dystrophy in Istria: Molecular Genetic Approach. Part II: Analysis of Genetic Polymorphisms. Coll Antropol, 2000; 2: 287-294